SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-3ASR - Automatic shelf registration statement of securities of well-known seasoned issuers:
SEC Accession No. 0001193125-19-309197
Filing Date
2019-12-09
Accepted
2019-12-09 16:03:03
Documents
9
Effectiveness Date
2019-12-09

Document Format Files

Seq Description Document Type Size
1 S-3ASR d841609ds3asr.htm S-3ASR 335174
2 EX-4.4 d841609dex44.htm EX-4.4 350811
3 EX-4.5 d841609dex45.htm EX-4.5 349841
4 EX-4.6 d841609dex46.htm EX-4.6 45314
5 EX-4.7 d841609dex47.htm EX-4.7 46498
6 EX-5.1 d841609dex51.htm EX-5.1 32411
7 EX-23.1 d841609dex231.htm EX-23.1 1655
8 GRAPHIC g841609g11b15.jpg GRAPHIC 35097
9 GRAPHIC g841609g1207084531455.jpg GRAPHIC 2016
  Complete submission text file 0001193125-19-309197.txt   1214057
Mailing Address 215 FIRST STREET SUITE 200 CAMBRIDGE MA 02142
Business Address 215 FIRST STREET SUITE 200 CAMBRIDGE MA 02142 617-714-0555
CONSTELLATION PHARMACEUTICALS INC (Filer) CIK: 0001434418 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-3ASR | Act: 33 | File No.: 333-235417 | Film No.: 191275320
SIC: 2834 Pharmaceutical Preparations